Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
Recommendations on data sharing in HIV drug resistance research.
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.